Behcet Syndrome
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Eye Diseases; Skin and Connective Tissue Diseases; Stomatognathic Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
502
|
243
|
0.700 |
None |
0.939 |
98 |
2
|
1980 |
2019 |
Stevens-Johnson Syndrome
|
disease |
Skin and Connective Tissue Diseases; Immune System Diseases; Chemically-Induced Disorders; Stomatognathic Diseases
|
Disease or Syndrome
|
67
|
16
|
0.700 |
None |
0.987 |
79 |
1
|
2004 |
2020 |
Ankylosing spondylitis
|
disease |
Musculoskeletal Diseases
|
Disease or Syndrome
|
710
|
609
|
0.500 |
None |
0.955 |
179 |
4
|
1980 |
2020 |
Toxic Epidermal Necrolysis
|
disease |
Skin and Connective Tissue Diseases; Immune System Diseases; Chemically-Induced Disorders; Stomatognathic Diseases
|
Disease or Syndrome
|
143
|
29
|
0.500 |
None |
0.958 |
95 |
1
|
2004 |
2020 |
HIV Infections
|
group |
Infections; Immune System Diseases
|
Disease or Syndrome
|
807
|
142
|
0.500 |
None |
1.000 |
36 |
4
|
2003 |
2019 |
Takayasu Arteritis
|
disease |
Skin and Connective Tissue Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
136
|
55
|
0.500 |
None |
0.960 |
25 |
2
|
1993 |
2018 |
Schizophrenia
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
2872
|
2897
|
0.430 |
None |
1.000 |
6 |
9
|
2006 |
2019 |
Hypersensitivity
|
group |
Immune System Diseases
|
Pathologic Function
|
90
|
2
|
0.410 |
None |
1.000 |
3 |
1
|
2007 |
2017 |
Stevens-Johnson Syndrome Toxic Epidermal Necrolysis Spectrum
|
disease |
Skin and Connective Tissue Diseases; Immune System Diseases; Chemically-Induced Disorders; Stomatognathic Diseases
|
Disease or Syndrome
|
50
|
1
|
0.400 |
None |
0.963 |
27 |
1
|
2004 |
2019 |
Exanthema
|
phenotype |
Skin and Connective Tissue Diseases
|
Sign or Symptom
|
251
|
14
|
0.400 |
None |
0.909 |
11 |
|
2006 |
2019 |
Drug-Induced Liver Disease
|
phenotype |
Digestive System Diseases; Chemically-Induced Disorders
|
Disease or Syndrome
|
537
|
29
|
0.400 |
None |
0.900 |
10 |
|
2009 |
2019 |
Allergic Reaction
|
phenotype |
Immune System Diseases
|
Pathologic Function
|
197
|
1019
|
0.400 |
None |
1.000 |
2 |
1
|
2013 |
2017 |
Myasthenia Gravis
|
disease |
Neoplasms; Immune System Diseases; Nervous System Diseases
|
Disease or Syndrome
|
336
|
93
|
0.360 |
None |
1.000 |
8 |
|
1983 |
2018 |
Drug Eruptions
|
group |
Skin and Connective Tissue Diseases; Immune System Diseases; Chemically-Induced Disorders
|
Disease or Syndrome
|
41
|
|
0.320 |
None |
1.000 |
4 |
|
2009 |
2018 |
Glioma
|
disease |
Neoplasms
|
Neoplastic Process
|
3097
|
353
|
0.320 |
None |
1.000 |
3 |
|
2001 |
2011 |
Dermatitis
|
disease |
Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
496
|
16
|
0.320 |
None |
1.000 |
3 |
|
1986 |
2016 |
Drug-Induced Stevens Johnson Syndrome
|
disease |
Skin and Connective Tissue Diseases; Immune System Diseases; Chemically-Induced Disorders; Stomatognathic Diseases
|
Disease or Syndrome
|
31
|
|
0.310 |
None |
1.000 |
10 |
|
2004 |
2015 |
Myasthenia Gravis, Ocular
|
disease |
Neoplasms; Immune System Diseases; Nervous System Diseases
|
Disease or Syndrome
|
17
|
|
0.310 |
None |
1.000 |
3 |
|
1983 |
2015 |
Dermatomyositis
|
disease |
Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Nervous System Diseases
|
Disease or Syndrome
|
235
|
34
|
0.310 |
None |
1.000 |
2 |
|
1987 |
2018 |
Adult type dermatomyositis
|
disease |
Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Nervous System Diseases
|
Disease or Syndrome
|
218
|
31
|
0.310 |
None |
1.000 |
2 |
|
1987 |
2018 |
Synovitis
|
disease |
Musculoskeletal Diseases
|
Disease or Syndrome
|
197
|
|
0.310 |
None |
1.000 |
2 |
|
1987 |
2003 |
Mycoplasma-Induced Stevens-Johnson Syndrome
|
disease |
Skin and Connective Tissue Diseases; Immune System Diseases; Chemically-Induced Disorders; Stomatognathic Diseases
|
Disease or Syndrome
|
30
|
|
0.300 |
None |
1.000 |
9 |
|
2004 |
2014 |
Drug toxicity
|
group |
Chemically-Induced Disorders
|
Injury or Poisoning
|
86
|
|
0.300 |
None |
1.000 |
6 |
|
1980 |
2018 |
Adverse reaction to drug
|
group |
Chemically-Induced Disorders
|
Pathologic Function
|
87
|
|
0.300 |
None |
1.000 |
6 |
|
1980 |
2018 |
Drug Allergy
|
group |
Immune System Diseases; Chemically-Induced Disorders
|
Pathologic Function
|
37
|
|
0.300 |
None |
1.000 |
4 |
|
2002 |
2007 |